Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pittsburgh

About this trial

The goal of this study is to determine whether a mobile application that combines real-time sensor data and patient-reported symptoms to trigger care-team contact recommendations is feasible and beneficial for patients receiving chemotherapy. The main questions it aims to answer are:

* Is the mobile application feasible and acceptable to patients? * Do the alerts and guidance improve symptom management, quality of life, and engagement with the care team during treatment?

Participants will:

* Complete a demographic questionnaire at the beginning of the study and quality-of-life and health questionnaires at the beginning, midpoint, and end of study. * Complete daily symptom ratings. * Wear a Fitbit activity tracker for 90 days. * At the end of the study, complete a semi-structured interview to provide feedback on the study. * Optional: At the beginning and end of the study, complete an in-person physical function assessment measuring balance (Short Physical Performance Battery).

Eligibility criteria

Qualifiers

Receiving chemotherapy at the UPMC Hillman Cancer Center for any solid tumor cancer at any stage with at least two cycles remaining;

age 18 years or older;

ability to read and write in English;

sufficient performance status to participate in research (e.g., Karnofsky performance status of 60-100%); and

Disqualifiers

under 18 years old; and

unable to read and write in English

Trial design

Treatments tested in this trial

  • Mobile Symptom Monitoring and Alert App

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Pittsburgh

Lead sponsor

National Cancer Institute (NCI)

Collaborator